Figure 1
From: Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
Omentin levels in axSpA and controls. Reduced serum (a) and mRNA expression (b) levels of omentin in axSpA patients when compared to healthy controls, after adjustment for potential confounding factors. Horizontal bars in Fig. 1a indicate the mean value of each group.
